North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19

被引：8

作者：

Bergsland, Emily K. ^{[1
]}

Halperin, Daniel M. ^{[2
]}

Dillon, Joseph S. ^{[3
]}

Dasari, N. Arvind ^{[4
]}

Kunz, Pamela L. ^{[5
]}

Soares, Heloisa P. ^{[6
]}

Pryma, Daniel ^{[7
]}

Bodei, Lisa ^{[8
]}

Hope, Thomas ^{[9
]}

Soulen, Michael C. ^{[7
]}

Mailman, Josh ^{[10
]}

Howe, James R. ^{[11
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA

[3] Univ Iowa, Dept Med, Carver Coll Med, Iowa City, IA 52242 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA

[5] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA

[6] Univ Utah Hlth, Dept Med, Salt Lake City, UT USA

[7] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[9] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA

[10] NorCal CarciNET Community, Ripon, CA USA

[11] Univ Iowa, Dept Surg, Carver Coll Med, Iowa City, IA 52242 USA

来源：

PANCREAS | 2020年 / 49卷 / 06期

关键词：

EVEROLIMUS;

D O I：

10.1097/MPA.0000000000001561

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：723 / 728

页数：6

共 5 条

[1] Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors [J].

Brabander, Tessa ;

van der Zwan, Wouter A. ;

Teunissen, Jaap J. M. ;

Kam, Boen L. R. ;

Feelders, Richard A. ;

de Herder, Wouter W. ;

van Eijck, Casper H. J. ;

Franssen, Gaston J. H. ;

Krenning, Eric P. ;

Kwekkeboom, Dik J. .

CLINICAL CANCER RESEARCH, 2017, 23 (16) :4617-4624

[2] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors [J].

Strosberg, J. ;

El-Haddad, G. ;

Wolin, E. ;

Hendifar, A. ;

Yao, J. ;

Chasen, B. ;

Mittra, E. ;

Kunz, P. L. ;

Kulke, M. H. ;

Jacene, H. ;

Bushnell, D. ;

O'Dorisio, T. M. ;

Baum, R. P. ;

Kulkarni, H. R. ;

Caplin, M. ;

Lebtahi, R. ;

Hobday, T. ;

Delpassand, E. ;

Van Cutsem, E. ;

Benson, A. ;

Srirajaskanthan, R. ;

Pavel, M. ;

Mora, J. ;

Berlin, J. ;

Grande, E. ;

Reed, N. ;

Seregni, E. ;

Oberg, K. ;

Sierra, M. Lopera ;

Santoro, P. ;

Thevenet, T. ;

Erion, J. L. ;

Ruszniewski, P. ;

Kwekkeboom, D. ;

Krenning, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02) :125-135

[3] Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics [J].

Thapa, Pradeep ;

Ranade, Rohit ;

Ostwal, Vikas ;

Shrikhande, Shailesh V. ;

Goel, Mahesh ;

Basu, Sandip .

NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (10) :1030-1037

[4] Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study [J].

Yao, James C. ;

Fazio, Nicola ;

Singh, Simron ;

Buzzoni, Roberto ;

Carnaghi, Carlo ;

Wolin, Edward ;

Tomasek, Jiri ;

Raderer, Markus ;

Lahner, Harald ;

Voi, Maurizio ;

Pacaud, Lida Buboteishvili ;

Rouyrre, Nicolas ;

Sachs, Carolin ;

Valle, Juan W. ;

Delle Fave, Gianfranco ;

Van Cutsem, Eric ;

Tesselaar, Margot ;

Shimada, Yasuhiro ;

Oh, Do-Youn ;

Strosberg, Jonathan ;

Kulke, Matthew H. ;

Pavel, Marianne E. .

LANCET, 2016, 387 (10022) :968-977

[5] Everolimus for Advanced Pancreatic Neuroendocrine Tumors. [J].

Yao, James C. ;

Shah, Manisha H. ;

Ito, Tetsuhide ;

Bohas, Catherine Lombard ;

Wolin, Edward M. ;

Van Cutsem, Eric ;

Hobday, Timothy J. ;

Okusaka, Takuji ;

Capdevila, Jaume ;

de Vries, Elisabeth G. E. ;

Tomassetti, Paola ;

Pavel, Marianne E. ;

Hoosen, Sakina ;

Haas, Tomas ;

Lincy, Jeremie ;

Lebwohl, David ;

Oberg, Kjell .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :514-523

← 1 →